NASDAQ:CLXTCalyxt Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Calyxt Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $3.43 +0.34 (+11.00 %) (As of 04/7/2020 07:12 AM ET) Add Compare Share Today's Range$3.15Now: $3.43▼$3.4550-Day Range$2.48MA: $4.40▼$6.7252-Week Range$2.40Now: $3.43▼$17.90Volume65,838 shsAverage Volume133,561 shsMarket Capitalization$113.16 millionP/E RatioN/ADividend YieldN/ABeta2.44 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. operates as a subsidiary of Cellectis S.A.Read More Beat the Market (BTM) Rank™ 3.2 Analyst's Opinion Consensus RatingCalyxt has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $11.00, Calyxt has a potential upside of 220.7% from its current price of $3.43.Amount of Analyst CoverageCalyxt has only been the subject of 4 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesCalyxt has received 242 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCalyxt has received 243 “underperform” votes. (Add your “underperform” vote.)Community SentimentCalyxt has received 50.10% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Calyxt and other stocks. Vote “Outperform” if you believe CLXT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CLXT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCalyxt does not currently pay a dividend.Dividend GrowthCalyxt does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Calyxt insiders have sold 948.94% more of their company's stock than they have bought. Specifically, they have bought $5,200.00 in company stock and sold $54,545.00 in company stock.Percentage Held by InsidersOnly 2.30% of the stock of Calyxt is held by insiders.Percentage Held by InstitutionsOnly 24.46% of the stock of Calyxt is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Calyxt are expected to grow by 0.74% in the coming year, from ($1.36) to ($1.37) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Calyxt is -2.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Calyxt is -2.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCalyxt has a P/B Ratio of 1.81. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.2Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.27 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Agricultural chemicals Sub-IndustryN/A SectorConsumer Staples Current SymbolNASDAQ:CLXT Previous Symbol CUSIPN/A CIK1705843 Webhttp://www.calyxt.com/ Phone651-683-2807Debt Debt-to-Equity Ratio0.29 Current Ratio8.83 Quick Ratio8.47Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$7.30 million Price / Sales15.50 Cash FlowN/A Price / Cash FlowN/A Book Value$1.90 per share Price / Book1.81Profitability EPS (Most Recent Fiscal Year)($1.21) Net Income$-39,610,000.00 Net Margins-543.00% Return on Equity-52.37% Return on Assets-39.74%Miscellaneous Employees50 Outstanding Shares32,990,000Market Cap$113.16 million Next Earnings Date5/5/2020 (Estimated) OptionableNot Optionable Receive CLXT News and Ratings via Email Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:CLXT Rates by TradingView Calyxt (NASDAQ:CLXT) Frequently Asked Questions How has Calyxt's stock been impacted by COVID-19 (Coronavirus)? Calyxt's stock was trading at $3.34 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CLXT shares have increased by 2.7% and is now trading at $3.43. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Calyxt? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Calyxt. When is Calyxt's next earnings date? Calyxt is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Calyxt. How were Calyxt's earnings last quarter? Calyxt Inc (NASDAQ:CLXT) released its earnings results on Thursday, March, 5th. The company reported ($0.37) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.33) by $0.04. The firm had revenue of $3.76 million for the quarter. Calyxt had a negative return on equity of 52.37% and a negative net margin of 543.00%. View Calyxt's earnings history. What guidance has Calyxt issued on next quarter's earnings? Calyxt issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, March, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $13.862-15.322 million, compared to the consensus revenue estimate of $20.48 million. What price target have analysts set for CLXT? 5 brokers have issued 12-month price targets for Calyxt's shares. Their forecasts range from $6.00 to $16.00. On average, they expect Calyxt's share price to reach $11.00 in the next twelve months. This suggests a possible upside of 220.7% from the stock's current price. View analysts' price targets for Calyxt. What are Wall Street analysts saying about Calyxt stock? Here are some recent quotes from research analysts about Calyxt stock: 1. According to Zacks Investment Research, "Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as offers fat saturation and gluten reduction in soybean oil and wheat. Calyxt, Inc. is based in New Brighton, United States. " (3/12/2020) 2. National Securities analysts commented, " Second Quarter Shows Progress And Growing Pains. With low and lumpy volumes in its first year of commercialization and weather issues reducing planted acreage from prior estimates, CLXT’s second quarter brought a degree of near term revenue uncertainty. OpEx also moved up sequentially more than we estimated. While a modest disappointment, we consider the improvement in distribution network and the market acceptance of the lead product to be encouraging and far more important to the value proposition. Customer Adoption Accelerates. With 20 customers currently, up from low single digits since the first quarter, we believe the market for both oil and meal is strong. As the company builds scale, we do not believe securing customers will be a meaningful hurdle. The next major bar is securing from consumer goods customers, which we expect over the next twelve months. Guilt By Association. Unwinnable tariff wars and weather challenges have dragged down Ag stocks this year. We believe CLXT is less exposed to these issues and can actually benefit from weak markets given its differentiated product offering in a commoditized space, yet the stock has underperformed its peers with more exposure to these variables. Lower Price Target, But Deep Value Opportunity. We believe the declines of 66% from its YTD high, and 32% in the past seven trading days alone are not justified and put the stock in deep value territory. Our lower price target is a reflection of adjustments to our model and assumed multiple, not a reflection of the value proposition which we believe remains significant." (8/8/2019) Has Calyxt been receiving favorable news coverage? News headlines about CLXT stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Calyxt earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutCalyxt. Are investors shorting Calyxt? Calyxt saw a decrease in short interest in the month of February. As of February 28th, there was short interest totaling 516,400 shares, a decrease of 14.8% from the February 13th total of 606,300 shares. Based on an average daily volume of 146,500 shares, the short-interest ratio is presently 3.5 days. Currently, 5.1% of the company's stock are sold short. View Calyxt's Current Options Chain. Who are some of Calyxt's key competitors? Some companies that are related to Calyxt include American Vanguard (AVD), CVR Partners (UAN), Marrone Bio Innovations (MBII), Wynnstay Group (WYN), Eden Research (EDEN), Arcadia Biosciences (RKDA), Evogene (EVGN), Bion Environmental Technologies (BNET), China Green Agriculture (CGA), SenesTech (SNES), Kiwa Bio-Tech Products Group (KWBT) and Cavitation Technologies (CVAT). What other stocks do shareholders of Calyxt own? Based on aggregate information from My MarketBeat watchlists, some companies that other Calyxt investors own include Cellectis (CLLS), Cypress Semiconductor (CY), Molecular Templates (MTEM), Advanced Micro Devices (AMD), GW Pharmaceuticals PLC- (GWPH), Intel (INTC), Netflix (NFLX), Secureworks (SCWX), AbbVie (ABBV) and Eaton (ETN). Who are Calyxt's key executives? Calyxt's management team includes the following people: Mr. James A. Blome, Chief Exec. Officer (Age 56)Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 56)Mr. Manoj Sahoo, Chief Commercial Officer (Age 44)Mr. William F. Koschak, Chief Financial Officer (Age 50)Mr. Eric Dutang, Principal Accounting Officer (Age 45) When did Calyxt IPO? (CLXT) raised $101 million in an IPO on Thursday, July 20th 2017. The company issued 6,100,000 shares at $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers. What is Calyxt's stock symbol? Calyxt trades on the NASDAQ under the ticker symbol "CLXT." How do I buy shares of Calyxt? Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Calyxt's stock price today? One share of CLXT stock can currently be purchased for approximately $3.43. How big of a company is Calyxt? Calyxt has a market capitalization of $113.16 million and generates $7.30 million in revenue each year. The company earns $-39,610,000.00 in net income (profit) each year or ($1.21) on an earnings per share basis. Calyxt employs 50 workers across the globe. View additional information about Calyxt. What is Calyxt's official website? The official website for Calyxt is http://www.calyxt.com/. How can I contact Calyxt? Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company can be reached via phone at 651-683-2807 or via email at [email protected] This page was last updated on 4/7/2020 by MarketBeat.com StaffFeatured Article: What are the economic characteristics of a bear market?
